ORGANOGENESIS HOLDINGS INC. Finance Lease, Liability, Payments, Due in Rolling Year Three
ORGANOGENESIS HOLDINGS INC. (ORGO) had Finance Lease, Liability, Payments, Due in Rolling Year Three of $1.46 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases › Finance Lease, Liability, to be Paid, Rolling Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueInRollingYearThree · last filed 2026-02-26
- 2025-12-31: Finance Lease, Liability, Payments, Due in Rolling Year Three $1.46M.
- 2024-06-30: Finance Lease, Liability, Payments, Due in Rolling Year Three $0.00.
- 2024-03-31: Finance Lease, Liability, Payments, Due in Rolling Year Three $0.00.
- 2023-12-31: Finance Lease, Liability, Payments, Due in Rolling Year Three $737.00K.
| Period end | Finance Lease, Liability, Payments, Due in Rolling Year Three | Finance Lease, Liability, Payments, Due in Rolling Year Three as first filed |
|---|---|---|
| 2025-12-31 | $1.46M 10-K · filed 2026-02-26 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $737.00K 10-K · filed 2024-02-29 | |
| 2023-09-30 | $737.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $61.00K 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $9.78M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $9.80M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |